These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15610240)

  • 1. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.
    Kim NH; Oh JH; Seo JA; Lee KW; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Kidney Int; 2005 Jan; 67(1):167-77. PubMed ID: 15610240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.
    Cha DR; Kang YS; Han SY; Jee YH; Han KH; Han JY; Kim YS; Kim NH
    J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice.
    Kosugi T; Nakayama T; Li Q; Chiodo VA; Zhang L; Campbell-Thompson M; Grant M; Croker BP; Nakagawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F609-16. PubMed ID: 20015944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.
    Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L
    Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and sFlt-1 in preeclampsia placenta].
    Sun SG; Shen N; Zheng YH; Shang T
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):440-4. PubMed ID: 17083805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients.
    Kim HW; Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2009 Oct; 14(7):681-8. PubMed ID: 19796028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy].
    Yuan M; Tang R; Zhou Q; Liu K; Xiao Z; Pouranan V
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):448-57. PubMed ID: 23719521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
    Belgore FM; Blann AD; Lip GY
    Clin Sci (Lond); 2001 May; 100(5):567-75. PubMed ID: 11294698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes.
    Bus P; Scharpfenecker M; Van Der Wilk P; Wolterbeek R; Bruijn JA; Baelde HJ
    Diabetologia; 2017 Sep; 60(9):1813-1821. PubMed ID: 28620823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and its soluble receptor, Flt-1, are not correlated to erythropoietin in diabetics with normal or reduced renal function.
    Lenz T; Gauer S; Weich HA; Haak T; Bergner R; Gossmann J
    Nephrology (Carlton); 2005 Feb; 10(1):84-9. PubMed ID: 15705187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers.
    Belgore FM; Lip GY; Blann AD
    Br J Biomed Sci; 2000; 57(3):207-13. PubMed ID: 11050771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
    Lee EY; Shim MS; Kim MJ; Hong SY; Shin YG; Chung CH
    Exp Mol Med; 2004 Feb; 36(1):65-70. PubMed ID: 15031673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between urinary albumin and serum soluble fms-like tyrosine kinase 1 (sFlt-1) in normal pregnancy.
    Yoshimatsu J; Matsumoto H; Goto K; Shimano M; Narahara H; Miyakawa I
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):204-8. PubMed ID: 16426725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor in diabetic nephropathy.
    Lenz T; Haak T; Malek J; Gröne HJ; Geiger H; Gossmann J
    Kidney Blood Press Res; 2003; 26(5-6):338-43. PubMed ID: 14610338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II.
    Feliers D; Duraisamy S; Barnes JL; Ghosh-Choudhury G; Kasinath BS
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F521-9. PubMed ID: 15572520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta.
    Li H; Gu B; Zhang Y; Lewis DF; Wang Y
    Placenta; 2005; 26(2-3):210-7. PubMed ID: 15708122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of VEGF in kidney of diabetic rats].
    Chen ZJ; Yang YB; Huang SM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):633-6. PubMed ID: 17718428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.